APOLD1 and Venous thrombosis: Liao et al., observed that through suppressing the expression of TF via the PI3K/Akt pathway, the Apolipoprotein L domain containing 1 (APOLD1) was able to reduce thromboembolism in rat models of deep venous thrombosis (DVT) [43].